Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

Boehringer Ingelheim Stiftung announces the winner of the 2025 Heinrich Wieland Prize: Adrian R. Krainer of Cold Spring ...

Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...

Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

A new large study from Denmark finds no evidence that aluminum salts used in vaccines are tied to a higher risk of childhood ...

Under the agreement, Allarity will supply advanced transcriptome analysis services to support the partner’s efforts to ...

The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.